"TauRx Announces New Data from Phase 3 AD Study, LUCIDITY, at AAIC 2023"
Learn MoreA leader in Alzheimer's disease research
TauRx's mission is to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of neurodegenerative diseases caused through protein aggregation. We are currently conducting clinical trials.